CLNN — Clene Inc.

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$6.69
Market Cap$88.2M
Float10.1M
Shares Outstanding12.8M
Price/Sales (TTM)657.99
vs. Analyst Target+358.4% to analyst PT
Operating Margin (TTM)-13740.00%
Revenue (TTM)$134,000
Earnings Growth (YoY)61.40%
Dividend RateNone
Analyst Target Price$30.67 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $206,000 -$19.3M $141,000 -$17.0M
2021 $723,000 -$9.7M $434,000 -$8.3M
2022 $473,000 -$29.9M $447,000 -$25.6M
2023 $654,000 -$49.5M $533,000 -$43.2M
2024 $342,000 -$39.4M $272,000 -$33.7M
2025 $200,000 -$26.2M $157,000 -$21.6M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $27,000 -$7.4M
Sep 2025 $15,000 -$8.8M
Dec 2025 $77,000 -$9.2M
Mar 2026 $15,000 -$8.1M

Ownership & Float

Insider Ownership24.6%
Institutional Ownership22.4%
Short Float8.6%
% of All Funds Holding0.34%
Number of Funds Holding28

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$6.21Near-term / short-term trend
Weekly40-Week SMA$6.62Medium-term trend
Weekly80-Week SMA$5.30Cyclical trend (business cycle)
Weekly200-Week SMA$12.36Secular trend (multi-year)
Monthly10-Month SMA$6.72Near-term monthly trend
Monthly20-Month SMA$5.44Medium-term monthly trend
Monthly40-Month SMA$8.46Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$10.30 resistance 2.67x 4 months ago
$3.50 support 1.32x 8 months ago

Historical Earnings Reactions (30 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.07% 0.00% 43.33% 7.45% -8.09%
1 Day -0.61% 0.00% 36.67% 9.58% -11.73%
1 Week -1.06% -0.23% 43.33% 57.22% -34.18%
2 Weeks 0.61% 0.00% 48.28% 47.78% -27.04%
1 Month 4.82% 0.49% 58.62% 71.39% -32.56%

Next earnings: August 2, 2026 (66 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-0.0%50.0%8
Feb13.0%62.5%8
Mar-1.7%37.5%8
Apr-7.0%37.5%8
May-0.4%71.4%7
Jun5.4%71.4%7
Jul-6.7%42.9%7
Aug5.8%57.1%7
Sep-7.2%14.3%7
Oct5.6%42.9%7
Nov-3.1%75.0%8
Dec-10.2%37.5%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.13% 39.9% 358
Tuesday -0.22% 36.0% 394
Wednesday 0.46% 37.4% 390
Thursday -0.33% 32.5% 382
Friday -0.07% 34.1% 384

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 22.4%

Insider Transactions — Smart Summary

Total insider ownership: 24.6%

Founder-led management: Mark Mortenson (Chief Science Officer)

12-Month Insider Activity Summary

Total Filings29
Net Value+N/A
Net Shares Change-519,972
% of Float-5.1%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Ugwumba Chidozie -$2.6M 9 9 sell
MATLIN DAVID J +$216,664.5 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-13 Ugwumba Chidozie -$604,134.049 Transaction at $6.33, now +5.7%
2026-05-05 Ugwumba Chidozie -$530,438.082 Transaction at $6.74, now -0.8%
2026-04-30 Ugwumba Chidozie -$112,778.447 Transaction at $5.78, now +15.7%
2026-04-22 Ugwumba Chidozie -$403,085.458 Transaction at $6.14, now +9.0%
2026-04-17 Ugwumba Chidozie -$251,897.816 Transaction at $6.43, now +4.0%
2026-04-06 Ugwumba Chidozie -$119,889.25 Transaction at $4.81, now +39.1%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Clene Inc. (CLNN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CLNN on Trend Edge →